Announcements Trials
Browse Landscape

Status

No longer available 2Available 1

Sponsor Class

INDUSTRY 8OTHER 3

Study Type

Interventional 770Observational 217Expanded_access 3

Sponsor

Cancer Type

CNS 3Dermatologic 1

Conditions

Prostatic Neoplasms 16Neoplasms 11Neuroblastoma 9Lambert-Eaton Myasthenic Syndrome 7Recurrence 6Precursor Cell Lymphoblastic Leukemia-Lymphoma 6Multiple Myeloma 6Leukemia 6Carcinoma, Hepatocellular 6Pheochromocytoma 5Lymphoma 5Leukemia, Myeloid, Acute 5Osteosarcoma 4Neuroendocrine Tumors 4Myelodysplastic Syndromes 4Liver Neoplasms 4Leukemia, Myelogenous, Chronic, BCR-ABL Positive 4Glioblastoma 4Sarcoma 3Precancerous Conditions 3Paraganglioma 3Pancreatic Neoplasms 3Neuroectodermal Tumors, Primitive 3Insulinoma 3Immunologic Deficiency Syndromes 3Hematologic Neoplasms 3Glioma 3Carcinoid Tumor 3Breast Neoplasms 3Sarcoma, Ewing 2

Interventions

pembrolizumab 1Vaccination 1Ipilimumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Expanded_access × Glioma × Clear all
NCT05356312 2024-03-01

Glioblastoma and Individualized Therapies

Zentrum fur Humangenetik Tuebingen

Available
CNS

Glioma

NCT03460782 2019-11-08

An Expanded Access Program of Ipilimumab for Patients With Glioblastomas and Gliomas

Center Trials & Treatment

No longer available
CNS

Glioblastoma, Glioma

NCT03311542 2018-01-10

Expanded Access for Pembrolizumab (MK-3475)

Center Trials & Treatment

No longer available
CNSDermatologic

Glioblastoma, Glioma, Melanoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡